|
Market Closed -
Swiss Exchange
12:30:30 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 70.80 CHF | -0.98% |
|
+3.36% | +29.43% |
| 10-27 | Basilea Pharmaceutica Lifts FY26 Guidance | MT |
| 10-27 | Basilea raises full-year guidance 2026 and financial target for "Agenda 2030" and provides updates on late-stage clinical programs | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BASILEA PHARMACEUTICA AG | Other Biotechnology & Medical Research | -0.98% | +3.36% | +29.43% | +52.26% | +65.27% | 1.07B |  | | |
- Stock Market
- Stocks
- BSLN Stock
- Charts Basilea Pharmaceutica AG
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
